The thirty-day programme is not a clinical finding. It is an artefact of how American treatment came to be reimbursed, and it has quietly shaped what families believe recovery is: a defined period, completed, after which someone is finished.
The follow-up research describes something different.
Recovery is measured in years
When researchers stopped measuring outcomes at discharge and started following people for years, the picture changed considerably.
Dennis and colleagues (2005) tracked how long it actually took people to stop for good. Two medians from that work are worth sitting with:
- 27 years from a person’s first use to their last use.
- 9 years from their first treatment episode to their last use.
Nine years, from the first time someone gets help to the last time they use. Against that, a thirty-day programme is not a course of treatment. It is one event fairly early in a long sequence.
The same study found 47% reached at least twelve months of continuous abstinence within three years of entering treatment — so this is not a counsel of despair. It is a statement about timescale.
Hser and colleagues (2001) followed a cohort of people with heroin dependence over more than three decades. Across that span the pattern was one of a long-running condition with periods of use, periods of abstinence and periods of instability — not a single event with a before and an after.
McLellan and colleagues (2000) put the argument in the form that has been most influential since: that substance dependence behaves like other chronic medical conditions, and that judging it by whether someone is well at the end of an acute treatment episode misunderstands what kind of condition it is.
The practical implication is uncomfortable but useful. Discharge is not the finish line. It is roughly the point at which the real work starts, and it is also the point at which most support stops.
What that means for the period right after treatment
If recovery unfolds over years, the weeks immediately after a residential stay are not the end of anything. They are a transition — and transitions are where things tend to come apart.
The specific problem is that everything protective disappears at once. A month of structure, supervision, routine and constant company ends on a single day, and the person returns to the same house, the same phone, the same commute, the same colleagues and the same difficult hour of the evening. What they carry back is a set of strategies that have only ever been practised somewhere safe.
That is a lot of change to absorb in twenty-four hours, at the exact moment someone’s coping reserves are lowest.
So how long?
The honest answer is that it depends on the person, and anyone who gives you a confident number without knowing the situation is guessing.
But the research supports a few things clearly enough to plan around.
Support should be measured against the person’s trajectory, not against a programme’s calendar. The question is not “have they done their thirty days” but “how are they actually doing, and in which direction.”
The step down should be gradual. Going from total structure to no structure in one day is the arrangement that fails. Intensity that reduces over weeks and months, rather than ending abruptly, matches how the risk actually falls.
Monitoring matters longer than intensity does. A high level of hands-on support is usually needed for a defined period. Some form of continued contact remains valuable long after daily support has ended, because the timeline in the research runs for years, not weeks.
There is direct evidence for this. Scott and colleagues (2005) randomly assigned 448 people either to assessment alone or to proactive quarterly check-ins. The check-in group returned to treatment significantly sooner when they needed it. The same study found about a third of participants moved between relapse, treatment and recovery in any given quarter — 82% changed state at least once over two years. Someone checking in quarterly sees that; someone waiting to be called does not.
Plan in months, review often. Most families we work with begin with a period of intensive support through the transition, then reduce. What matters is that the reduction is planned and reviewed, rather than happening because a package ran out.
Worth knowing which way the odds run: Dennis and colleagues found time to recovery was significantly longer for men, for people who started using before 21 — particularly before 15 — for those who had already been through treatment three or more times, and for people carrying high mental distress. None of those is destiny. All of them are arguments for planning longer rather than shorter.
The more useful question
Rather than how long will this take, the question worth asking is: what is the support for, and what will replace it?
Support after treatment is not there to keep somebody sober indefinitely by external effort. That does not work and nobody can afford it. It is there to hold the structure in place while the person builds their own — a routine, a set of relationships, work, a reason to get up, the things that will eventually do the job that the support is doing now.
Measured that way, “how long” has a real answer: until the thing being propped up can stand on its own. That is visible, and it varies enormously between people.
What this looks like in practice
For most people leaving residential treatment, the highest-value period is the first stretch back at home — which is precisely the period that is usually unsupported, because the programme has ended and outpatient appointments are weekly at best.
That gap is what sober companion care exists to fill: someone present through the transition, at reducing intensity, until the person’s own structure is doing the work.
If you are planning for someone coming home in the next few weeks, the thing worth doing now is deciding what day thirty-one actually looks like — before it arrives.
References
- Dennis ML, Scott CK, Funk R, Foss MA (2005). The duration and correlates of addiction and treatment careers. Journal of Substance Abuse Treatment. 10.1016/j.jsat.2004.10.013
- Hser YI, Hoffman V, Grella CE, Anglin MD (2001). A 33-Year Follow-up of Narcotics Addicts. Archives of General Psychiatry, 58, 503-508. 10.1001/archpsyc.58.5.503
- McLellan AT, Lewis DC, O’Brien CP, Kleber HD (2000). Drug Dependence, a Chronic Medical Illness. JAMA, 284, 1689-1695. 10.1001/jama.284.13.1689
- Scott CK, Dennis ML, Foss MA (2005). Utilizing Recovery Management Checkups to shorten the cycle of relapse, treatment reentry, and recovery. Drug and Alcohol Dependence, 78, 325-338. 10.1016/j.drugalcdep.2004.12.005
Read more about Personal Recovery Assistant.
